Medical devices

  • COMPAMED 2016 connected medical devices and people

    Materialise NV from Belgium speaking on “Innovation in 3D Printed Wearables” at COMPAMED HIGH-TECH Forum 2016. IVAM

    Miniaturized connected systems and outstanding business contacts: forming networks on both technical and business level was one of the key features of COMPAMED 2016, the international trade fair for suppliers and manufacturers of medical technologies. This trend was visible at and enhanced by the joint trade fair booth of the IVAM Microtechnology Network in hall 8a, the accompanying presentation forum and numerous B2B meetings between companies from Germany and Japan.

  • Enough is enough - stem cell factor Nanog knows when to slow down

    STILT generates simulated protein expression of dividing cells based on measured data and a dynamic model. Source: Helmholtz Zentrum München

    The transcription factor Nanog plays a crucial role in the self-renewal of embryonic stem cells. Previously unclear was how its protein abundance is regulated in the cells. Researchers at the Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with colleagues from ETH Zürich, now report in ‘Cell Systems’ that the more Nanog there is on hand, the less reproduction there is. Every stem cell researcher knows the protein Nanog* because it ensures that these all-rounders continue to renew. A controversial debate revolved around how the quantity of Nanog protein in the cell is regulated.

  • New Products - Highlights of COMPAMED 2016

    NanEye - The award winning, smallest digital camera in the world, for disposable endoscope. CMOSIS Germany GmbH

    COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

  • Official launch of the International Consortium for Personalised Medicine, ICPerMed

    Brussels, Belgium, November 2016. Personalised medicine¹ is a promising new concept for dealing with challenges of health and health systems. With the launch of the International Consortium of Personalised Medicine (ICPerMed), European countries aim to coordinate health research policy to advance the implementation of personalised medicine. The initiative brings together health research funders and policy making organisations from 28 countries, five regions and the European Commission (EC)².

  • Personalized antibiotic treatment

    The electrochemical biosensor system for point-of-care testing. Photo: Andreas Weltin

    Researchers from Freiburg have developed a sensor platform that quantifies antibiotics in human blood within minutes. A team of researchers from the University of Freiburg has developed a system inspired by biology that can detect several different antibiotics in human blood or other fluids at the same time. This biosensor system could be used for medical diagnostics in the future, especially for point-of-care testing in doctors’ practices, on house calls and in pharmacies, as well as in environmental and food safety testing. The researchers focused their study on the antibiotics tetracycline and streptogramin in human blood.